1580
We report a 16-year-old male who developed nephrotic syndrome related to membranous glomerulopathy with clinical and serological evidence of systemic lupus erythematosus after treatment with griseofulvin.
 a 16-year-old male: Subject; 16-year-old: Subject.Age; male: Subject.Gender; nephrotic syndrome related to membranous glomerulopathy with clinical and serological evidence of systemic lupus erythematosus: Effect; treatment with griseofulvin: Treatment; griseofulvin: Treatment.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 a 16-year-old male: Subject; 16-year-old: Subject.Age; male: Subject.Gender; nephrotic syndrome related to membranous glomerulopathy with clinical and serological evidence of systemic lupus erythematosus: Effect; treatment with griseofulvin: Treatment; griseofulvin: Treatment.Drug